The company’s brain-computer interface is implanted in a blood vessel on the brain’s surface and is designed to restore the capability for severely paralyzed patients to control devices with hands-free point-and-click, according to a Dec. 15 Synchron news release.
The financing will be used to launch a clinical trial.
ARCH Venture Partners led the financing, bringing Synchron’s total capital raised to $145 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
